Cited by 2,415Birth, Development, and HealthPregnancy and preeclampsia studiesBlood Pressure and Hypertension Studies

Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.

Open access
Barker, D. J., Osmond, C., Golding, J., Kuh, D., Wadsworth, M. E.·1989·BMJ

Abstract

In national samples of 9921 10 year olds and 3259 adults in Britain systolic blood pressure was inversely related to birth weight. The association was independent of gestational age and may therefore be attributed to reduced fetal growth. This suggests that the intrauterine environment influences blood pressure during adult life. It is further evidence that the geographical differences in average blood pressure and mortality from cardiovascular disease in Britain partly reflect past differences in the intrauterine environment. Within England and Wales 10 year olds living in areas with high cardiovascular mortality were shorter and had higher resting pulse rates than those living in other areas. Their mothers were also shorter and had higher diastolic blood pressures. This suggests that there are persisting geographical differences in the childhood environment that predispose to differences in cardiovascular mortality.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.298.6673.564

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • An adverse intrauterine environment renders offspring vulnerable to death as neonates and more likely to acquire heart disease later if they survive childhood.

    “Thus, they suggested that an adverse intrauterine environment rendered them vulnerable to death as neonates, and more likely to acquire heart disease later if they survived childhood (33).”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [33]

  • The Barker team reasoned that both the neonates and adults died for the same reason, namely that their development had been compromised before birth.

    “The Barker team reasoned that both the neonates and adults died for the same reason, namely that their development had been compromised before birth.”

    From Placental Origins of Chronic Disease (2016) · cites this paper as [33]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 16

  1. the two outputs obtained simultaneouslv from the finger. J Biomed Eng 1988;10:458-62.
  2. Cooke ED, Bowcock SA, Smith AT. A mathematical model for the sascular behaviour of the hands in response to cold stress. l'ascular Medicine 1985;3:98-104.
  3. Bennett T, Hosking DJ, Hampton JR. Cardiovascular responses to lower body negative pressure in normal subjects and in patients with diabetes mellitus. Cardiovasc Res 1979;13:31-8.
  4. Winston EL, Pariser KM, Miller KB, et al. Nifedipine as a therapeutic modality for Raynaud's phenomenon. Arthritis Rheum 1983;26:1177-80.
  5. Rodeheffer RJ, Rommer JA, Wigley F, S mth CR. Controlled double-blmd trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl] Med 1983;308:880-3.
  6. Souza J, Kraus A, Gonzalez-Amaro R, Alarcon-Segovia D. Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A con- trolled double-blind trial. J Rheumatol 1984;11:362-4.
  7. Kahar A, Weber S, Amor B, et al. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Rev Rhum Mal Osteoartic 1982;49: 337-43.
  8. Kenny J. Calcium channel blocking agents and the heart. Br Med J 1985;291:1 150-2.
  9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle. Nature 1980;288:373-6.
  10. Singer HA, Peach MJ. Endothelium-dependent relaxation of rabbit aorta 1 and 2. J Pharmnacol Exp Ther 1983;226:790-801.
  11. Aldoori M, Campbell WB, Dieppe PA. Nifedipine in the treatment of Raynaud's syndrome. Cardiovasc Res 1986;20:466-70.
  12. Rademaker MT, Kirby JDT, Kovacs IB. Altered in-vitro clotting and thrombolysis after oral nifedipine in normal volunteers. Angiology (in press.)
  13. Blunt RJ, George AJ, Hurlow RA, Strachan CJL, Stuart J. Hyperviscosity and thrombotic changes in idiopathic and secondary Raynaud's syndrome. BrJ Haematol 1980;45:651-8. (Accepted 23 December 1988)
  14. Notkola V. Living conditions in childhood and coronary heart disease in adulthood. Helsinki: Finnish Society of Science and Letters, 1985.
  15. Gardner MJ, Winter PD, Barker DJP. Atlas ofmortality from selected diseases in England and Wales 1968-78. Chichester: John Wiley, 1984.
  16. Cater J, Gill M. The follow-up study: medical aspects. In: IlIsley R, Mitchell RG, eds. Low birth weight, a medical psychological and social study. Chichester: John Wiley, 1984:191-205.

Cited by

Sorted by citations

Authors
Barker, D. J., Osmond, C., Golding, J., Kuh, D., & Wadsworth, M. E.
Affiliations
Southampton General Hospital (GB)
Venue
BMJ
Publisher
BMJ
Published
1989-03-04
Volume
298
Issue
6673
Pages
564-567
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2073974662
Cited by
2,415
References
26
Citations by year
2026: 36 · 2025: 54 · 2024: 63 · 2023: 66 · 2022: 81 · 2021: 78 · 2020: 74 · 2019: 91 · 2018: 106 · 2017: 89 · 2016: 123 · 2015: 105 · 2014: 113 · 2013: 119 · 2012: 120
FWCI
24.23
Type
journal article
Language
en
Open access
Locations
  • BMJ (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Explore Bristol Research (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
fetal growth, birth weight, systolic blood pressure, childhood blood pressure, adult blood pressure, cardiovascular mortality, intrauterine environment, gestational age, regional variation, maternal height, pulse rate, diastolic blood pressure
MeSH terms
Adult, Aging, Birth Weight, Blood Pressure, Body Height, Cardiovascular Diseases, Child, Female, Embryonic and Fetal Development, Gestational Age, United Kingdom, Humans, Infant, Newborn, Male, Mothers, Pulse

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review